IP vs IRD
International Paper (IP) versus Opus Genetics, Inc. (IRD) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
IP does not have a complete income-statement cache yet.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
IP currently screens at market cap $26.62B and trailing P/E 43.1. IRD currently screens at market cap $35.7M.
Not investment advice. Open the IP and IRD stock pages for the full models.
Not investment advice.